Application Nr Approved Date Route Status External Links
ANDA078633 None Sublingual None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Buprenorphine Sublingual Tablets Are Indicated For The Treatment Of Opioid Dependence And Are Preferred For Induction. Buprenorphine Sublingual Tablets Should Be Used As Part Of A Complete Treatment Plan To Include Counseling And Psychosocial Support. Buprenorphine Sublingual Tablets Contain Buprenorphine, A Partial Opioid Agonist, And Is Indicated For The Treatment Of Opioid Dependence And Is Preferred For Induction. ( 1 ) Buprenorphine Sublingual Tablets Should Be Used As Part Of A Complete Treatment Plan That Includes Counseling And Psychosocial Support. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Buprenorphine Hydrochloride BUPRENORPHINE HYDROCHLORIDE ZINC100373348

Comments